These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32514194)

  • 21. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 22. Russian SARS-CoV-2 vaccine.
    Caddy S
    BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
    [No Abstract]   [Full Text] [Related]  

  • 23. The COVID-19 vaccine development landscape.
    Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
    Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
    [No Abstract]   [Full Text] [Related]  

  • 24. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

  • 25. [SARS coronavirus-2 vaccines: options and state-of-the-art].
    Huckriede ALW
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 27. Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Sep; 383(11):e88. PubMed ID: 32905696
    [No Abstract]   [Full Text] [Related]  

  • 28. Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
    Bull World Health Organ; 2020 Sep; 98(9):588-589. PubMed ID: 33012858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
    Avorn J; Kesselheim A
    JAMA; 2020 Oct; 324(13):1284-1285. PubMed ID: 32870268
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
    Abbasi J
    JAMA; 2020 Sep; 324(12):1125-1127. PubMed ID: 32880613
    [No Abstract]   [Full Text] [Related]  

  • 31. Status of COVID-19 vaccine development.
    Taxt AM; Grødeland G; Lind A; Müller F
    Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'I've never worked harder': the race to develop a COVID-19 vaccine.
    Woolston C
    Nature; 2020 Nov; 587(7833):322. PubMed ID: 33168971
    [No Abstract]   [Full Text] [Related]  

  • 33. Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    Strassle C; Jardas E; Ochoa J; Berkman BE; Danis M; Rid A; Taylor HA
    N Engl J Med; 2020 Nov; 383(20):1897-1899. PubMed ID: 33085884
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use.
    Edwards KM; Orenstein WA
    J Pediatr; 2020 Sep; 224():124-128. PubMed ID: 32565096
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible method for the production of a Covid-19 vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Mar; 186(12):388. PubMed ID: 32221001
    [No Abstract]   [Full Text] [Related]  

  • 36. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines.
    Forman R; Anderson M; Jit M; Mossialos E
    Vaccine; 2020 Sep; 38(39):6075-6077. PubMed ID: 32773244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
    McPartlin SO; Morrison J; Rohrig A; Weijer C
    BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
    Ayoub BM
    Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID-19 vaccines: no time for complacency.
    The Lancet
    Lancet; 2020 Nov; 396(10263):1607. PubMed ID: 33220729
    [No Abstract]   [Full Text] [Related]  

  • 40. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.